Mechanochemistry towards greener pharmaceuticals
Innovative processes to revolutionise how we manufacture drugs and chemicals
Greener pharma
The pharmaceutical industry generates tons of toxic waste and carbon emissions. Moreover, it often relies on the supply chains of chemicals and catalysts, which limits timely production during emergencies.
Mechano…what?
Mechanochemistry gets rid of solvents. It uses mechanical force, like grinding and milling, to drive chemical reactions. It’s succesfully used by other industrial sectors (aerospace, cosmetics, fertilisers…). Now, IMPACTIVE will validate its use in pharma.
An impactful solution
IMPACTIVE is a project funded by the European Commission, which counts on 17 partners in 10 different countries. Our expertise covers the whole value chain, from research to industry and innovation, which will ensure our solutions find ways to market.
Strong industrial collaboration
IMPACTIVE counts with the industry from the start. 2 international companies (Merck & Novartis) are part of the project, to help with the scaling up.
News
+ Go to news page
Register for the first IMPACTIVE webinar!
We’re launching our IMPACTIVE webinar series to discuss mechanochemistry, green pharmaceuticals, and green chemistry. Save the date: our first session will take place on 28 May at 12:00 pm (noon) CEST, with a presentation by Evelina Colacino, our project coordinator.

Back to basics: the cyclical history of solvents
Behind the manufacture of millions of everyday products lies a key constant: the use of solvents. Their unique properties have driven significant progress in the chemical industry. However, due to their polluting and often toxic characteristics, it is now urgent to reconsider how (and when) we use them. Sometimes, to find the simplest solutions, all we need to do is seek the answers in nature.

The French Ambassador to Estonia has visited us!
Emmanuel Mignot visited the Institut Charles Gerhardt Montpellier (ICGM) at the University of Montpellier, France, to discover more about IMPACTIVE. It was an exceptional opportunity to exchange ideas and strengthen relations with our Estonian partners.